726 results on '"Saibara, Toshiji"'
Search Results
2. Molecular Diagnosis and Targeting of Biliary Tract Cancer
3. Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease
4. Lack of 17β-estradiol reduces sensitivity to insulin in the liver and muscle of male mice
5. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study
6. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells
7. Monocytic elastase-mediated apolipoprotein-E degradation: Potential involvement of microglial elastase-like proteases in apolipoprotein-E proteolysis in brains with Alzheimers disease
8. A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice
9. KIF20A-Mediated RNA Granule Transport System Promotes the Invasiveness of Pancreatic Cancer Cells
10. Prevalence of pruritus in patients with chronic liver disease: A multicenter study
11. Molecular Diagnosis and Targeting of Biliary Tract Cancer
12. A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
13. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey
14. Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH)
15. Tamoxifen-Induced Nonalcoholic Steatohepatitis
16. Regulatory Mechanism of Cationic Amino Acid Transporters in Hepatic Sinusoidal Ito Cells
17. High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non‐alcoholic fatty liver disease patients before development of diabetes mellitus
18. Morphological Aspects of Hepatic Fibrosis and Ito Cells (Hepatic Stellate Cells), with Special Reference to Their Myofibroblastic Transformation
19. Biphasic effect of alcohol intake on the development of fatty liver disease
20. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
21. Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
22. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
23. The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease
24. Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice
25. Aromatase-null mice expressing enhanced green fluorescent protein in germ cells provide a model system to assess estrogen-dependent ovulatory responses
26. Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice
27. Characterization of Ovarian Responses to Equine Chorionic Gonadotropin of Aromatase-Deficient Mice With or Without 17β-Estradiol Supplementation
28. # 1033 BCL7B enhances cell motility and invasion of pancreatic cancer cells
29. Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study
30. A Novel Noninvasive Diagnostic Method for Nonalcoholic Steatohepatitis Using Two Glycobiomarkers
31. Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis
32. Liver acid sphingomyelinase inhibits growth of metastatic colon cancer
33. Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis
34. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels
35. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
36. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
37. A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
38. The latest idea in NAFLD/NASH pathogenesis
39. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease
40. Ruvbl1 directly binds actin filaments and induces formation of cell protrusions to promote pancreatic cancer cell invasion: P-508
41. Upper limit of normal serum alanine aminotransferase levels in Japanese subjects
42. Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1
43. Expression of fascin-1, an actin-bundling protein, in migrating hepatoblasts during rat liver development
44. Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice
45. Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature
46. Vascularization in tissue remodeling after rat hepatic necrosis induced by dimethylnitrosamine
47. Are genetic variations the most important risk factors for development of hepatocellular carcinoma?
48. A novel type hypertriglyceridemia observed in FLS mice
49. Vinculin: a novel marker for quiescent and activated hepatic stellate cells in human and rat livers
50. Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar−/−) mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.